As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
At Hetero Healthcare, our Speciality Care portfolio is designed to address complex and chronic medical conditions with high-quality, evidence-based therapies. From life-saving medications to innovative formulations, this division manufactures every product under rigorous quality standards to provide healthcare professionals with trusted solutions that meet the highest standards of quality, safety, and efficacy.
View by-
